A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in ...

New online course to improve nurses' knowledge of lupus, including diagnosis, treatment and providing support throughout the care continuum.

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment ...

The Lupus Foundation of America (LFA) and Lupus Canada are pleased to announce Mohamed Osman, MD, PhD, Associate Professor of ...

The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) with or without ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage BCMAxCD3 bispecific T cell engager.

This week, the American College of Rheumatology (ACR) released updated guidelines for the treatment and management of systemic lupus erythematosus (SLE), the most common form of lupus. The new ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.